Close Menu

codevelopment agreement

The company signed separate agreements with AstraZeneca, Merck, Merck KGaA, and Pfizer to create the panel, which is expected to help speed drug development.

The companies will co-develop kits, which Trovagene will distribute globally, to analyze ctDNA from blood or urine using next-generation sequencing platforms.

The partners will offer pharmaceutical firms a complete next-generation sequencing-based solution for the development and commercialization of companion diagnostic tests.

The two companies said they will integrate their technologies to create a sample management and interpretation and reporting system.

China-based Burning Rock will develop cancer diagnostics for Chinese patients based on the Agilent SureSelect target enrichment system.

The planned solution will enable secondary and tertiary analysis and visualization of single-cell sequence data.

The company said its organic revenue growth during the quarter was 4 percent, and that acquisitions increased revenue by 3 percent.

As part of a development and global distribution agreement, the companies will develop and launch a kit directed towards mitigating a growing HAI-related concern.

Thermo Fisher will become the exclusive distributor for a technology to be developed with Boston-based Cytonome.

The assay will detect multiple classes of genomic alterations across a range of genes involved in homologous recombination repair.

Pages

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.